Clinical Trial Update: Ranolazine in Atrial Fibrillation Following An ELectricaL CardiOversion [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating ranolazine for atrial fibrillation after electrical cardioversion has completed, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation

Drugs mentioned

• Ranolazine (ranolazine)

Snippet

Sponsor: Menarini Group | Conditions: Persistent Atrial Fibrillation | Phase 2 | Status: COMPLETED | Results posted: 2014-08-19